These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 862189)

  • 41. Infarction of the midgut associated with oral contraceptives. Report of two cases.
    Brennan MF; Clarke AM; Macbeth WA
    N Engl J Med; 1968 Nov; 279(22):1213-4. PubMed ID: 5687397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral contraceptives and intrahepatic biliary cystadenoma having an increased level of estrogen receptor.
    Suyama Y; Horie Y; Suou T; Hirayama C; Ishiguro M; Nishimura O; Koga S
    Hepatogastroenterology; 1988 Aug; 35(4):171-4. PubMed ID: 3181863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ethynodiol diacetate and a combination-type oral contraceptive compound on carbohydrate metabolism. II. One year intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1977 Apr; 13(2):89-91. PubMed ID: 856654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angioneurotic edema from an oral contraceptive.
    Wolf RL
    JAMA; 1967 Sep; 201(12):982. PubMed ID: 12254853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ethynodiol diacetate and combination--type oral contraceptive compounds on carbohydrate metabolism. I. Six month intravenous glucose tolerance study.
    Goldman JA
    Diabetologia; 1975 Feb; 11(1):45-8. PubMed ID: 1140518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic adenoma associated with oral contraceptive use: an unusual clinical presentation.
    Sears HF; Smith G; Powell RD
    Arch Surg; 1976 Dec; 111(12):1399-403. PubMed ID: 999507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives.
    Gattanell PN; Perloff M; Holland JF
    Med Pediatr Oncol; 1978; 4(2):99-103. PubMed ID: 207962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic incidentaloma: a modern problem.
    Little JM; Kenny J; Hollands MJ
    World J Surg; 1990; 14(4):448-51. PubMed ID: 2166378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical aspects of the administration of gestagen preparations (Volidan, Cyclofarlutal, Ovulen, Ciba AC-101 and Steridil)].
    Sternadel Z
    Ginekol Pol; 1970 Jul; 41(7):771-6. PubMed ID: 5453644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.
    Gyorffy EJ; Bredfeldt JE; Black WC
    Ann Intern Med; 1989 Mar; 110(6):489-90. PubMed ID: 2537593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis.
    Neuberger J; Portmann B; Nunnerley HB; Laws JW; Davis M; Williams R
    Lancet; 1980 Feb; 1(8163):273-6. PubMed ID: 6101735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histological changes in the ovary under the effect of oral contraceptive.
    Achari K
    J Obstet Gynaecol India; 1969 Dec; 19():737-40. PubMed ID: 12254872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatic sinusoidal ectasia.
    Oligny LL; Lough J
    Hum Pathol; 1992 Aug; 23(8):953-6. PubMed ID: 1644440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of long-term therapy with an oral contraceptive on some aspects of hepatic lipid metabolism in vitro.
    Weinstein I; Belitsky R; Seedman S; Friegly MJ; Trasher TN
    Biochem Pharmacol; 1975 Sep; 24(17):1583-8. PubMed ID: 1191317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertriglyceridemia during treatment with estrogen and oral contraceptives. An alteration in hepatic function?
    Gershberg H; Hulse M; Javier Z
    Obstet Gynecol; 1968 Feb; 31(2):186-9. PubMed ID: 5638742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant hypertension with irreversible renal failure due to oral contraceptives.
    Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
    Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compatibility of oral contraceptive with anti-tubercular chemotherapy in female pulmonary tuberculosis patients.
    Mehrotra ML; Gautam KD; Pande DC; Chaube CK; Dixit R; Malhotra A; Kushwaha S
    Indian J Med Res; 1974 Nov; 62(11):1782-6. PubMed ID: 4448525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives.
    Grigsby P; Meyer JS; Sicard GA; Huggins MB; Lamar DJ; DeSchryver-Kecskemeti K
    J Surg Oncol; 1987 Jul; 35(3):173-9. PubMed ID: 2439848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.